비소세포폐암에서 COX-2, MMP-9와 돌연변이형p53의 발현이 생존에 대한 예후 분석
Prognostication by Cluster Analysis of COX-2, MMP-9 and P53 Expresion and by Clinico-pathologic Correlation Analysis in Non-small Cell Lung Cancer
유재형 (중앙대학교)
최재호 (대진대학교)
박인원 (중앙대학교)
- 다운로드 수
- 조회수
초록
연구배경: 폐암의 병인에 기여하거나 예후를 결정하는 인자에 대해서는 매우 다양한 인자와 다양한 상호 관계로 인하여 특히 유전자의 역할에 대해서는 결정적으로 알려진 것이 없어 앞으로 더 많은 연구가 필요한 실정이다. 이에 따라 본 연구에서는 COX-2, MMP-9, p53가 비소세포폐암에서 어떻게 발현되는지 세포면역학적으로 알아보고 임상 특성과 예후와 상관관계를 알아보고자 하였다.대상 및 방법: 91명의 비소세포폐암을 대상으로 하여 후향적으로 임상특성을 고찰하고 COX-2, MMP- 9, p53의 유전자 표현을 세포면역학적 방법을 통하여 검사하였다. 임상특성과 유전자 표현 패턴의 상관관계와 생존에 대한 예후인자로서의 역할에 대하여 조사하였다.결 과: 1) 편평상피세포암에서는 흡연자과 남자가 우세한 비율을 차지하였으며 남자에서 흡연의 비율이 유의하게 높았다. 2) 전체 대상 환자에서 생존에 영향을 미치는 결정적인 인자는 근치적 절제술의 시행여부와 병기로 나타났다. 3) COX-2의 발현은 편평상피세포암 보다 선암에서 더 유의하게 높게 발현되었다. 4) COX-2, MMP-9, p53의 발현이 모두 되지 않는 비율은 선암에 비해 편평상피세포암에서 더 흔하게 관찰되었다. 5) p53돌연변이가 있으면서 COX-2와 MMP-9은 발현이 되지 않는 비소세포폐암환자의 생존기간이 다른 발현 양상을 보이는 경우에서의 생존기간보다 더 연장되어 보였다(생존기간의 중앙값; 165.6주). 6) COX-2의 발현과 MMP-9의 발현 사이에는 유의한 상관관계가 있었다. 7) 폐암을 근치적으로 절제한 환자의 경우에 COX-2의 발현은 유의한 예후인자였다.MMP-9는 근치적 절제술을 받지 못한 환자군에서 유의한 예후인자로 작용하였다.
- keywords
- COX-2, MMP-9, P53, Non-small cell lung cancer., COX-2, MMP-9, P53, Non-small cell lung cancer.
Abstract
Background: In pathogenesis and prognosis of lung cancer, significance of enormous types of genetic expression were very compounding and undetermined. We performed this study to search association between clinical characteristics and expression of COX-2, MMP-9 and p53 in non-small cell lung cancer. Methods: Ninety-one patients with adenocarcinoma or squamous cell carcinoma were enrolled. We had searched clinical data retrospectively and performed immunohistochemical staining for COX-2, MMP-9 and p53. We had analyzed significance of these three genes in clinical features and prognosis for survival. Results: 1) In squamous cell carcinoma, male was predominant and was significantly correlated with smoking. 2) Major prognostic determinants for overall survival were curative resection. 3) Expression of COX-2 was more frequent in adenocarcinoma than in squamous cell carcinoma. 4) Negative staining of COX-2, MMP-9 and p53 was more frequent in squamous cell carcinoma than adenocarcinoma. 5) Survival duration was longer in the group with positive expression of p53 and negative for COX-2 and MMP-9 (median duration of survival = 165.6 weeks) than groups with the other expressional patterns. 6) Significant correlation was found between expression of MMP-9 and COX-2. In squamous cell carcinoma, expression of MMP-9, COX-2 and mutant p53 were mutually correlated. 7) COX-2 expression was significant prognostic factor for survival in resected cancer group. In unresected inoperable non-small cell lung cancer group, MMP-9 was statistically significant prognostic factor for overall survival. Conclusion: COX-2 and MMP-9 might have some roles for progression or prognosis in some selected patients with non-small cell lung cancer. COX-2 and MMP-9 may have some roles for disease progression or prognosis in selected patients with NSCLC. (Tuberc Respir Dis 2007; 63: 31-41)
- keywords
- COX-2, MMP-9, P53, Non-small cell lung cancer., COX-2, MMP-9, P53, Non-small cell lung cancer.
참고문헌
(2005) Global cancer statistics, 2002,
(1998) Genetic instabilities in human cancers,
(1951-4.) et al. Detection of chromosomal polysomy in oral leukoplakia,
(1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation,
(2001) The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis ,
(2001) Genetic instability in epithelial tissues at risk for cancer,
Sidransky D. Microsatellite alterations as clonal markers for the detection of human cacner. Proc Natl Acad Sci U S A 1994,
(1997) Prognostic value of replication errors on chromosomes 2p and 3p in non-small cell lung cancer,
(1996) Fractional allele loss data indicate distinct genetic populations in the development of non-small cell lung cancer,
(1997) Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors ,
(1999) Sequential molecular abnormalities are involved in the multistage development of squamous cell carcinoma,
(2000) Prognostic implications of microsatellite alteration profiles in early-stage non-small cell lung cancer,
(1996) Extensive areas of aneuploidy are present in the respiratory epithelium of lung cancer patients,
Smejkal W. Field cancerization in oral stratified squamous epithelium clinical implications of multicentric origin. Cancer 1953,
(2001) Long-term impact of smoking on lung epithelial proliferation in current and former smokers,
(1999) Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation,
(1999) Cyclooxygenase-2 expression in hepatocellular carcinoma,
(1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer,
(1999) Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer : a population-based study,
DuBois RN. Upregualtion of cyclooxygenase 2 gene expression human colorectal adenomas and adenocarcinomas. Gastroenterology 1994,
(1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer,
(2004) Multifaceted roles of cyclooxygenase-2 in lung cancer,
(2003) Control of apoptosis by p53,
(2003) p53 and regulation of DNA damage recognition during nucleotide excision repair,
(2002) p53 regulation of DNA excision repair pathways,
(2003) Clinical value of p53, c-erbB2, CEA and CA125 regrding relapse, metastasis and death in resectable non-small cell-lung cancer,
(2003) Expression of p53, pRB, and p16 in lung tumors: a validation study on tissue microarrays,
(1998) Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications,
(2001) Molecular biologic markers and micrometastasis in resected non-small cell lung cancer,
(1999) Correlation of abnormal p16INK4A and p53 expression with 3p loss of heterozygosity and clinical features in 103 primary non-small cell lung cancers,
(2003) P53 and Bcl-2 protein expression and its relationship with prognosis in small-cell lung cancer,
(1999) Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer,
(1999) Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms,
(2006) Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome,
(2005) Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer,
(2001) Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer,
(2004) Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer,
(2004) Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment,
(2004) COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung,
(2003) Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung,
- 다운로드 수
- 조회수
- 0KCI 피인용수
- 0WOS 피인용수